Pentamidine-loaded poly(D,L-lactide) nanoparticles: Adsorption and drug release

Drug Development Research

Volumn 43, Issue 2, 1998, Pages 98-104

  Paul, Muriel ^a,d   Laatiris, Abdelkader ^a   Fessi, Hatem ^b   Dufeu, Barbara ^a   Durand, Rémy ^c   Deniau, Michèle ^c   Astier, Alain ^a  

^a Pharmacie   (France)

^b UNIVERSITÉ LYON 1   (France)

^c FACULTÉ DE MÉDECINE   (France)

^d NONE   (France)

Author keywords

Adsorption; Pentamidine; Poly(lactide) nanoparticles; Release

Indexed keywords

METHACRYLIC ACID; NANOPARTICLE; PENTAMIDINE; PENTAMIDINE ISETHIONATE; POLOXAMER; POLY(DEXTRO LEVO LACTIDE) NANOPARTICLE; POLYGLACTIN; POLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CYTOTOXICITY; DILUTION; DRUG ADSORPTION; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; IONIC STRENGTH; MICHAELIS CONSTANT; MOUSE; NONHUMAN; SPECTROSCOPY; STATISTICAL ANALYSIS; TEMPERATURE;

EID: 0031844605     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199802)43:2<98::AID-DDR2>3.0.CO;2-K     Document Type: Article

References (25)

1. Alving CR (1986): Liposomes as drug carriers in leishmaniasis and malaria. Parasitol Today 2:101-107.
2. Banerjee G, Nandi G, Mahato SB, Pakrashi A, Basu MK (1996): Drug delivery system-targeting of pentamidines to specific sites using sugar grafted liposomes. J Antimicrob Chemother 38(1):145-150.
3. Berman JD, Gallalee JV, Williams JS, Hockmeyer WD (1988): Activity of pentamidine-containing human red cell ghosts against visceral leishmaniasis in the Hamster. Am J Trop Med Hyg 35:297-302.
4. Couvreur P, Kante B, Roland M, Guiot P, Bauduin P, Speiser P (1979): Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: Preparation, morphological and sorptive properties. J Pharm Pharmacol 31:331-332.
5. Davidson RN, Croft SL (1993): Recent advances in the treatment of visceral leishmaniasis. Trans Royal Soc Trop Med 87:130-131.
6. Deniau M, Durand R, Bories C, Paul M, Astier H, Couvreur P, Houin R (1993): Etude in vitro de médicaments leishmanicides vectorisés. Ann Parasitol Hum Comp 68:34-37.
7. Durand R, Paul M, Rivollet D, Honin R, Astier H, Deniau M (1997a): Activity of pentamidine-loaded methacrylate nanoparticles against Leishmania infantum in a mouse model. Int J Parasitol 27:1361-1367.
8. Durand R, Paul M, Rivollet D, Houin R, Astier H, Deniau M (1997b): Activity of pentamidine loaded poly(D,L-lactide) nanoparticles against Leishmania infantum in a mouse model. Parasite 4:331-336.
9. El Egakey MA, Speiser P (1982): Drug loading studies on ultrafine solid carriers by Sorption procedures. Pharm Acta Helv 57:236-240.
10. Fessi H, Devissaguet JP, Puisieux F, Thies C (1992): Process for preparation of dispersible colloidal systems of a substance in the form of nanoparticles. U.S. Patent No. 5,118,528.
11. Fusai T. Deniau M, Durand R, Bories C, Paul M, Rivollet D, Astier A, Houin R (1994). Action of pentamidine bound nanoparticles against Leishmania on an in vivo model. Parasite 1:319-324.
12. Gaspar R, Opperdoes FR, Préat V, Roland M (1992): Drug targeting with polyalkylcyanoacrylate nanoparticles: In vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani. Ann Trop Med Parasitol 86:41-49.
13. Guterres SS, Fessi H, Barrat G, Devissaguet JP, Puisieux F (1995): Poly(DL-lactide) nanocapsules containing diclofenac: Formulation and stability study. Int J Pharm 113:57-63.
14. Illum L, Khan MA, Mak E, Davis SS (1986): Evaluation of carrier capacity and release characteristics for poly(butyl 2-cyanoacrylate) nanoparticles. Int J Pharm 30:17-28.
15. Kulkarni RK, Moore EG, Hegyeli AF, Leornarde F (1971): Biodegradable poly(lactic acid) polymers. J Biomed Mater Res 5:169-181.
16. Modabber F (1992): Leishmaniasis. In Maurice J, Pierce AM (eds): Tropical Disease Research Progress 91-92, Eleventh Program Report. Geneva: World Health Organization, pp 77-81.
17. Nemati E Dubernet C, Colin de Verdière A, Poupon MF, Treupel-Acar L, Puisieux F, Couvreur P (1994): Some parameters influencing cytotoxicity of free doxorubicin and doxorubicin-loaded nanoparticles in sensitive and multidrug resistant leucemic murine cells: Incubation time, number of nanoparticles per cell. Int J Pharm 102:55-62.
18. Paul M, Durand R, Boulard Y, Fusai T, Fernandez C, Rivollet D, Deniau M, Astier A (1997a): Physicochemical characteristcs of pentamidine-loaded polymethacrylate nanoparticles: Implication in the intracellular drug release in Leishmania major infected mice. J Drug Target (in press).
19. Paul M, Fessi H, Laatiris A, Boulard Y, Durand R, Deniau M, Astier A (1997b): Pentamidine-loaded poly(D,L-lactide) nanoparticles: Physicochemical properties and stability study. Int J Pharm 159:223-232.
20. Puisieux F, Barrat G, Couarraze G, Couvreur P, Devissaguet JP, Dubernet C, Fattal Y, Fessi H, Vauthier C (1994): Polymeric micro and nanoparticles as drug carriers. In Severian Dimitriu (ed): Polymeric Biomaterials. New York: Marcel Dekker, pp 749-794.
21. Rodrigues JM Jr, Fessi H, Bories C, Puisieux F, Devissaguet JPh (1995): Primaquine-loaded poly(lactide) nanoparticles: Physicochemical study and acute tolerance in mice. Int J Pharm 126:253-260.
22. Rolland A (1987): Mise au point et applications de nanospheres à base de copolymères methacryliques. Intérêt pour la vectorisation d'agents cytostatiques (anthracyclines). PhD Thesis, Université de Rennes, France.
23. Vernier-Julienne MC, Vouldoukis Monjour L, Benoit JP (1995): In vitro of the antileishmanial activity of biodegradable nanoparticles. J Drug Target 3:23-29.
24. Youssef M, Fattal E, Couvreur P, Adremont A (1988): Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles. Antimicrob Agents Chemother 33:1204-1207.
25. Zografi G (1995): Interfacial phenomena. In Gennaro AR (ed): Remington: The Science and Practice of Pharmacy, 19th ed. Easton, Pennsylvania, USA: Mac Publishing, p 249.